HomePodcastsThe Long Run with Luke TimmermanEp195: Ken Song on T-cell Engagers for Autoimmune DiseasesThe Long Run with Luke TimmermanEp195: Ken Song on T-cell Engagers for Autoimmune DiseasesMarch 3, 2026 · 1 h 6 minPlay episodeShare from this pointShow notesKen Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.All episodes of The Long Run with Luke Timmerman